These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9642373)

  • 1. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
    Zhao X; Zhang L; Gong S
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
    Ye H; Huang G; Pei L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
    Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
    Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles.
    Karlström PO; Bergh T; Lundkvist O
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):37-42. PubMed ID: 10646814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
    Hara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ovulation induction therapies on endometrial integrin alpha v beta 3 expression in patients with polycystic ovarian syndrome related infertility].
    Wang Y; Chen Y; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):163-5. PubMed ID: 11775896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.
    Orvieto R; Zagatsky I; Yulzari-Roll V; La Marca A; Fisch B
    Gynecol Endocrinol; 2006 Aug; 22(8):437-40. PubMed ID: 17012105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
    Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
    Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation.
    Frydman R; Cornel C; de Ziegler D; Taieb J; Spitz IM; Bouchard P
    Fertil Steril; 1991 Nov; 56(5):923-7. PubMed ID: 1936328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
    Molo MW; Rawlins RG; Binor Z; Kelly M; Radwanska E
    J Reprod Med; 1995 Jun; 40(6):418-22. PubMed ID: 7650652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short course of menotropin after clomiphene failure in infertile women with luteal phase defects.
    Wu CH
    J Reprod Med; 1989 Oct; 34(10):807-10. PubMed ID: 2507780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.